PUBLISHED DATE : Aug 2023 | Pages : 339
Fill out your details & get your free sample
The Healthcare Cold Chain Logistics Market Size, Share, & Trends Analysis Report by
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2023–2028.
339 Pages
76 Tables
183 Charts
5 Regions
18 Countries
31 Companies
4 Market Segment
| Report Attribute | Details |
|---|---|
| Market Size (2028) | USD 27.74 Billion |
| Market Size (2022) | USD 20.39 Billion |
| CAGR (2022-2028) | 5.26% |
| Base Year | 2022 |
| FORECAST YEAR | 2023-2028 |
| SEGMENTS BY | Product, Service, End-User, and Geography |
| GEOGRAPHIC ANALYSIS | North America, Europe, APAC, Latin America, and Middle East & Africa |
| KEY VENDORS | AmerisourceBergen, DB Group, Deutsche Post DHL Group, CEVA Logistics, United Parcel Service, FedEx, and Kuehne + Nagel |
The global healthcare cold chain logistics market was valued at USD 20.39 billion in 2022 and is expected to reach USD 27.74 billion by 2028, growing at a CAGR of 5.26%. Healthcare cold chain logistics deals with manufacturing, processing, shipping materials, and resources and activities related to handling manufactured goods by customers. Logistics companies play a crucial role in the functioning of any pharmaceutical company. The growing R&D spending to develop new drugs and therapies, rising demand for generic drugs and vaccines, and clinical trial materials are the major driving factors for the growth of the healthcare cold chain logistics market. The growing ocean freight for healthcare products shipments is one of the major factors driving the market's growth.
The COVID-19 pandemic has created complexities in the global supply chain that impacted all the modes of freight transportation, from air to rail cargo, which may take months or years to get back to normal.
The increasing demand for air ambulances is fueled by growing demand for organ transplants and emergency patient transfer. The demand for air ambulances is growing in the U.S. and Europe; however, it is expected to create lucrative opportunities in APAC and Latin America during the forecast period. The leading healthcare cold chain logistics also raises growing funds to support air ambulances. For instance, Deutsche Post DHL Group raised about USD 95,900 in 2021 for local air ambulance service.
Recently, clinical research has become highly globalized, with many of these studies being conducted across the globe and a significant increase in clinical trials in developing countries. The focus of clinical trial researchers is now shifting from developed markets of Japan, Australia, South Korea, and Singapore to emerging economies such as Thailand, China, the Philippines, and Vietnam.
Major companies strive to offer cloud-based supply chain services and secured supply chain functions such as blockchain technology and live tracking platform as they help healthcare companies safeguard the validity of their products. Vendors in the healthcare cold chain logistics market, such as FedEx and Nippon Express, are focused on developing their pioneering IoT technology to monitor and perform the live tracking of their shipments. These solutions are also expected to prevent the production and distribution of counterfeit drugs. According to DB Schenker, a subsidiary of DB Group, to increase transport density and reliability, the shift to digital rail operations and digitalization of infrastructure and vehicles is essential. In 2019, TrakCel, one of the global leaders in managing clinical supply chain logistics, partnered with Quick Group to provide industry-leading digital supply chain IT solutions for cell and gene therapies.
The recent emergence of cell and gene therapy is expected to create lucrative opportunities for the healthcare cold chain logistics market. Healthcare cold chain logistics providers increasingly focus on delivering value-added services to hospitals and clinics.
Many pharmaceutical drugs, medicines, and specialty treatments are temperature-sensitive and require swift supply chains. Cold chain storage and distribution provide a reliable mechanism to maintain the integrity of the drug substances and products. Production of pharmaceuticals is getting more complex as companies expand their product portfolio to align with the rapidly changing market and meet customers' needs. With the increasing number of chronic disease cases, the demand for modern healthcare products and services and improved medical assistance is also rising, especially in rural areas. Consecutively, this has generated a need for the safe transportation of pharma products. Healthcare manufacturers increasingly demand specialized healthcare cold chain logistics services to deliver efficient warehousing, transporting, and distribution services for large volumes of pharmaceuticals to hospitals, home care patients, labs, and other healthcare facilities. The growing demand for temperature-controlled products, especially pharmaceutical ones, with the development of many advanced therapies derived from human cells, has evoked the need for cold chain logistics and contributed to the healthcare cold chain logistics market growth.
INSIGHTS BY PRODUCT
The pharmaceuticals product segment dominated the global healthcare cold chain logistics market due to increasing demand for both branded and generic drugs and vaccines. Pharmaceuticals are imported and exported around the world on a massive scale. Aging populations and new drugs to treat rare and specialty diseases fuel this growth. North America and Europe are the major markets for the largest pharmaceutical segment share. About 97% of marketed drugs are classified as small molecules. Biologics will lead among the top-selling products and new sales generators projected for 2022, whereas small molecules will continue to lead in new drug approvals. According to the US FDA’s Center for Drug Evaluation and Research, of the 50 new molecular entities (NMEs) approved in 2021, 36 (72%) were small molecules, and 14 (28%) were biologics.
INSIGHTS BY FUNCTION
The global healthcare cold chain logistics market by service is segmented into transportation, warehousing, and others. As transportation is a crucial part of the logistics chain, it accounted for the highest revenue share of the market. Transportation is the most crucial part of cold chain logistics because the products are transported to the end-user. The demand for temperature-controlled transportation is also rising to maintain the quality of products. Furthermore, road transportation dominates the transportation segment, with a revenue share of over 66% in 2022. The highest share of road transportation can be attributed to its low cost in workforce and operation. In January 2021, over 58% of US-Canada cross-border freight was moved by trucks, followed by rail, with over 16% of cross-border freight.
However, in 2020, European land transport declined because of the COVID-19 pandemic. Between April and August 2020, after decreased prices and falling demand, prices grew exponentially compared to levels in October 2020, and the demand increased significantly. As air rates are higher in the healthcare cold chain logistics market than water and road, the demand for logistics through the air is lowest. Further, air freight is 78% more expensive than ocean freight, and it leads the pack with 80% of all temperature excursions for pharmaceutical products transportation. In comparison, ocean transportation has a 1% temperature excursion rate, while road transport is a little higher, with 18% of all the excursions.
INSIGHTS BY END-USER
The pharmaceutical/biotech companies' end-user segment accounted for the highest revenue share of the global healthcare cold chain logistics market in 2022. Pharmaceutical/biotech companies dominate the end-user segment because this segment is the primary manufacturer of healthcare products that are temperature sensitive and need cold chain logistics to ensure efficient and timely delivery of medications to the patients and to receive raw materials such as APIs to develop several pharmaceutical products. In recent years, it has been noticed that there is growing spending in cold chain logistics that is contributing to market growth. The revenue share of the pharmaceutical/biotech companies’ segment is expected to grow faster in APAC during the forecast period as APAC is a potential market for pharma industry growth.
North America accounted for the highest revenue share of over 37% of the global healthcare cold chain logistics market in 2022. The larger share is contributed by the increasing clinical trial spending, increasing spending on R&D activities to develop new drugs and the presence of top leading pharmaceutical companies. About five of the ten leading pharmaceutical companies in 2020 were from the United States. In the U.S., branded drugs accounted for around 83.9% of spending in the US alone. In 2020, about 8.1% of global drug and medicine shipments originated from North America. Further, North America and Europe accounted for about 80% of monoclonal antibodies. Thus, the demand for biologics, i.e., vaccines and monoclonal antibodies, is increasing investments in R&D. These are major factors driving the healthcare cold chain logistics market.
Europe is a major exporter of pharmaceutical drugs. For instance, Germany, Switzerland, and Ireland were the top three major exporters of pharmaceutical products in 2020. The demand for pharmaceutical logistics in Europe is driven by the growing demand for biologics, such as vaccines, propelled by the COVID-19 pandemic and growing investments from leading pharmaceutical firms. In 2019, sales of the pharmaceutical industry in the country increased by 5.7%, reaching about USD 52.1 billion. Over 500 pharmaceutical companies are in Germany. Small and mid-size enterprises (SMEs) are the backbone of the economic sector, with around 90% of drug manufacturers. In 2018, Germany generated a production value of USD 42.1 billion, making it Europe's leading pharmaceutical manufacturing country. North America and Europe are the leading countries with more organ transplants expected to create lucrative opportunities for air-based healthcare cold-chain logistics providers.
The global healthcare cold chain logistics market is highly fragmented and concentrated, with many key players in the industry. AmerisourceBergen, DB Group, Deutsche Post DHL Group, CEVA Logistics, United Parcel Service, FedEx, and Kuehne + Nagel are the significant players in the global healthcare cold chain logistics market. Vendors are increasingly focusing on integrating new advancements in their services to become more competitive and increase their profit margin. Some of these advancements include integrating blockchain technology to ensure safety and authenticity and avoid counterfeiting drug fraud. Further, several vendors, such as Kuehne+ Nagel, give a fully integrated “live tracking” platform for easy access to data regarding the shipment. In addition, FedEx, a key company, and Nippon Express provide safe and compliant transportation of temperature-sensitive shipments in pharma. Their shipments are enabled with real-time tracking and tracing data.
The prominent vendors also compete by offering cold chain transportation services and various warehousing services at competitive prices. However, the healthcare cold chain logistics market is highly dominated by major players, and other players are also focusing on providing low-cost logistics services to their customers. In addition, a few emerging companies are also focusing on healthcare-specific cold chain logistics services and advancing their shipment monitoring services by improving visibility. The vendors also focus more on ocean transportation to save costs, make larger shipments, and on environmentally friendly shipping.
Frequently Asked Questions
How big is the healthcare cold chain logistics market?
The global healthcare cold chain logistics market share was valued at USD 20.39 billion in 2022 and is expected to reach USD 27.74 billion by 2028.
What is the projected growth rate of the healthcare cold chain logistics market?
The healthcare cold chain logistics market is projected to grow at a CAGR of 5.26% during the forecast period.
Who are the key players in the global healthcare cold chain logistics market?
AmerisourceBergen, DB Group, Deutsche Post DHL Group, CEVA Logistics, United Parcel Service, FedEx, and Kuehne + Nagel are the key players in the global healthcare cold chain logistics market.
What are the growing trends in the healthcare cold chain logistics market?
The growing trends in the global healthcare cold chain logistics market are logistics control through the Internet of medical things, the emergence of blockchain technology, and direct-to-patient logistics services.
Which region holds the most significant global healthcare cold chain logistics market share?
North America dominated the global healthcare cold chain logistics market, accounting for over 37% in 2022.
The global healthcare cold chain logistics market size is expected to grow at a CAGR of approximately 5.26% from 2022 to 2028.
The following factors are likely to contribute to the growth of the healthcare cold chain logistics market during the forecast period:
Base Year: 2022
Forecast Year: 2023-2028
The report considers the present scenario of the healthcare cold chain logistics market and its market dynamics for 2023−2028. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the industry. It also profiles and analyzes leading companies and several other prominent companies operating in the industry.
Key Company Profiles
Other Prominent Vendors
Segmentation by Product
Segmentation by Service
Segmentation by End-User
Segmentation by Geography
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.2 MARKET SEGMENTATION BY PRODUCT
4.3.3 MARKET SEGMENTATION BY FUNCTION
4.3.4 MARKET SEGMENTATION BY FUNCTION
4.3.5 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 PREMIUM INSIGHTS
6.1 MARKET SCENARIO
7 MARKET AT A GLANCE
8 INTRODUCTION
8.1 OVERVIEW
9 MARKET OPPORTUNITIES & TRENDS
9.1 LOGISTICS CONTROL THROUGH INTERNET OF MEDICAL THINGS (IOMT)
9.2 ADOPTION OF BLOCKCHAIN TECHNOLOGY
9.3 EMERGENCE OF DIRECT-TO-PATIENT LOGISTICS SERVICES
10 MARKET GROWTH ENABLERS
10.1 RISE IN NUMBER OF CLINICAL TRIALS
10.2 INCREASING COLLABORATIONS BETWEEN 3PL PROVIDERS & HEALTHCARE PROVIDERS
10.3 SURGE IN DEMAND FOR GENERICS & BIOSIMILARS
10.4 INCREASE IN MASS IMMUNIZATION PROGRAMS
11 MARKET RESTRAINTS
11.1 LACK OF COMPLIANCE & CHANGING REGULATIONS
11.2 GEOPOLITICAL RISKS & FLUCTUATING INTERNATIONAL TRADE REGULATORY POLICIES
11.3 INBOUND LOGISTICS SERVICES FOR MANUFACTURERS
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
12.2.1 INSIGHTS BY PRODUCT
12.2.2 INSIGHTS BY SERVICE
12.2.3 INSIGHTS BY END USER
12.2.4 INSIGHTS BY GEOGRAPHY
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY
13 PRODUCT
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 PHARMACEUTICALS
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 MARKET BY GEOGRAPHY
13.4 MEDICAL PRODUCTS
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 MARKET BY GEOGRAPHY
13.5 OTHERS
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
13.5.3 MARKET BY GEOGRAPHY
14 SERVICE
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 TRANSPORTATION
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MARKET BY GEOGRAPHY
14.3.4 ROAD
14.3.5 MARKET OVERVIEW
14.3.6 MARKET SIZE & FORECAST
14.3.7 WATER
14.3.8 MARKET OVERVIEW
14.3.9 MARKET SIZE & FORECAST
14.3.10 AIR
14.3.11 MARKET OVERVIEW
14.3.12 MARKET SIZE & FORECAST
14.4 WAREHOUSING
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 MARKET BY GEOGRAPHY
14.5 OTHERS
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 MARKET BY GEOGRAPHY
15 END USER
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 PHARMACEUTICAL/BIOTECHNOLOGY COMPANIES
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 MARKET BY GEOGRAPHY
15.4 HOSPITALS & CLINICS
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 MARKET BY GEOGRAPHY
15.5 RESEARCH & DIAGNOSTIC LABORATORIES
15.5.1 MARKET OVERVIEW
15.5.2 MARKET SIZE & FORECAST
15.5.3 MARKET BY GEOGRAPHY
15.6 OTHERS
15.6.1 MARKET OVERVIEW
15.6.2 MARKET SIZE & FORECAST
15.6.3 MARKET BY GEOGRAPHY
16 GEOGRAPHY
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 GEOGRAPHIC OVERVIEW
17 NORTH AMERICA
17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
17.3 NORTH AMERICA: PRODUCT
17.4 NORTH AMERICA: SERVICE
17.5 NORTH AMERICA: END USER
17.6 KEY COUNTRIES
17.6.1 US: MARKET SIZE & FORECAST
17.6.2 CANADA: MARKET SIZE & FORECAST
18 EUROPE
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 EUROPE: PRODUCT
18.4 EUROPE: SERVICE
18.5 EUROPE: END USER
18.6 KEY COUNTRIES
18.6.1 GERMANY: MARKET SIZE & FORECAST
18.6.2 FRANCE: MARKET SIZE & FORECAST
18.6.3 UK: MARKET SIZE & FORECAST
18.6.4 ITALY: MARKET SIZE & FORECAST
18.6.5 SPAIN: MARKET SIZE & FORECAST
19 APAC
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 APAC: PRODUCT
19.4 APAC: SERVICE
19.5 APAC: END USER
19.6 KEY COUNTRIES
19.6.1 CHINA: MARKET SIZE & FORECAST
19.6.2 JAPAN: MARKET SIZE & FORECAST
19.6.3 INDIA: MARKET SIZE & FORECAST
19.6.4 SOUTH KOREA: MARKET SIZE & FORECAST
19.6.5 AUSTRALIA: MARKET SIZE & FORECAST
20 LATIN AMERICA
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 LATIN AMERICA: PRODUCT
20.4 LATIN AMERICA: SERVICE
20.5 LATIN AMERICA: END USER
20.6 KEY COUNTRIES
20.6.1 BRAZIL: MARKET SIZE & FORECAST
20.6.2 MEXICO: MARKET SIZE & FORECAST
20.6.3 ARGENTINA: MARKET SIZE & FORECAST
21 MIDDLE EAST & AFRICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.3 MIDDLE EAST & AFRICA: PRODUCT
21.4 MIDDLE EAST & AFRICA: SERVICE
21.5 MIDDLE EAST & AFRICA: END-USER
21.6 KEY COUNTRIES
21.6.1 TURKEY: MARKET SIZE & FORECAST
21.6.2 SAUDI ARABIA: MARKET SIZE & FORECAST
21.6.3 SOUTH AFRICA: MARKET SIZE & FORECAST
22 COMPETITIVE LANDSCAPE
22.1 COMPETITION OVERVIEW
22.1.1 AMERISOURCEBERGEN
22.1.2 DB GROUP
22.1.3 DEUTSCHE POST DHL
22.1.4 CEVA LOGISTICS
22.1.5 UNITED PARCEL SERVICE
22.1.6 FEDEX
22.1.7 KUEHNE+NAGEL
23 KEY COMPANY PROFILES
23.1 AMERISOURCEBERGEN
23.1.1 BUSINESS OVERVIEW
23.1.2 SERVICE OFFERINGS
23.1.3 KEY STRATEGIES
23.1.4 KEY STRENGTHS
23.1.5 KEY OPPORTUNITIES
23.2 DB GROUP
23.2.1 BUSINESS OVERVIEW
23.2.2 SERVICE OFFERINGS
23.2.3 KEY STRATEGIES
23.2.4 KEY STRENGTHS
23.2.5 KEY OPPORTUNITIES
23.3 DEUTSCHE POST DHL GROUP
23.3.1 BUSINESS OVERVIEW
23.3.2 SERVICE OFFERINGS
23.3.3 KEY STRATEGIES
23.3.4 KEY STRENGTHS
23.3.5 KEY OPPORTUNITIES
23.4 CEVA LOGISTICS
23.4.1 BUSINESS OVERVIEW
23.4.2 SERVICE OFFERINGS
23.4.3 KEY STRATEGIES
23.4.4 KEY STRENGTHS
23.4.5 KEY OPPORTUNITIES
23.5 UNITED PARCEL SERVICE
23.5.1 BUSINESS OVERVIEW
23.5.2 SERVICE OFFERINGS
23.5.3 KEY STRATEGIES
23.5.4 KEY STRENGTHS
23.5.5 KEY OPPORTUNITIES
23.6 FEDEX
23.6.1 BUSINESS OVERVIEW
23.6.2 SERVICE OFFERINGS
23.6.3 KEY STRATEGIES
23.6.4 KEY STRENGTHS
23.6.5 KEY OPPORTUNITIES
23.7 KUEHNE + NAGEL
23.7.1 BUSINESS OVERVIEW
23.7.2 SERVICE OFFERINGS
23.7.3 KEY STRATEGIES
23.7.4 KEY STRENGTHS
23.7.5 KEY OPPORTUNITIES
24 OTHER PROMINENT VENDORS
24.1 AWL INDIA
24.1.1 BUSINESS OVERVIEW
24.1.2 SERVICE OFFERINGS
24.2 ALLOGA
24.2.1 BUSINESS OVERVIEW
24.2.2 SERVICE OFFERINGS
24.3 A.P. MOLLER - MAERSK
24.3.1 BUSINESS OVERVIEW
24.3.2 SERVICE OFFERINGS
24.4 AZENTA
24.4.1 BUSINESS OVERVIEW
24.4.2 PRODUCT OFFERINGS
24.5 COLD CHAIN TECHNOLOGIES
24.5.1 BUSINESS OVERVIEW
24.5.2 SERVICE OFFERINGS
24.6 COREX LOGISTICS
24.6.1 BUSINESS OVERVIEW
24.6.2 SERVICE OFFERINGS
24.7 CARDINAL HEALTH
24.7.1 BUSINESS OVERVIEW
24.7.2 SERVICE OFFERINGS
24.8 DPD
24.8.1 BUSINESS OVERVIEW
24.8.2 SERVICE OFFERINGS
24.9 DSV
24.9.1 BUSINESS OVERVIEW
24.9.2 SERVICE OFFERINGS
24.10 FARMASOFT
24.10.1 BUSINESS OVERVIEW
24.10.2 SERVICE OFFERINGS
24.11 GXO LOGISTICS
24.11.1 BUSINESS OVERVIEW
24.11.2 SERVICE OFFERINGS
24.12 KERRY LOGISTICS NETWORK
24.12.1 BUSINESS OVERVIEW
24.12.2 PRODUCT OFFERINGS
24.13 LUFTHANSA CARGO
24.13.1 BUSINESS OVERVIEW
24.13.2 SERVICE OFFERINGS
24.14 LOGISTA
24.14.1 BUSINESS OVERVIEW
24.14.2 PRODUCT OFFERINGS
24.15 NIPPON EXPRESS
24.15.1 BUSINESS OVERVIEW
24.15.2 SERVICE OFFERINGS
24.16 NOATUM LOGISTICS
24.16.1 BUSINESS OVERVIEW
24.16.2 SERVICE OFFERINGS
24.17 PHOENIX GROUP
24.17.1 BUSINESS OVERVIEW
24.17.2 SERVICE OFFERINGS
24.18 PAREXEL INTERNATIONAL
24.18.1 BUSINESS OVERVIEW
24.18.2 SERVICE OFFERINGS
24.19 QUICK INTERNATIONAL COURIER
24.19.1 BUSINESS OVERVIEW
24.19.2 PRODUCT OFFERINGS
24.20 SEKO LOGISTICS
24.20.1 BUSINESS OVERVIEW
24.20.2 SERVICE OFFERINGS
24.21 SINOTRANS
24.21.1 BUSINESS OVERVIEW
24.21.2 SERVICE OFFERINGS
24.22 YOURWAY
24.22.1 BUSINESS OVERVIEW
24.22.2 SERVICE OFFERINGS
24.23 YUSEN LOGISTICS
24.23.1 BUSINESS OVERVIEW
24.23.2 SERVICE OFFERINGS
24.24 YSDS
24.24.1 BUSINESS OVERVIEW
24.24.2 PRODUCT OFFERINGS
25 REPORT SUMMARY
25.1 KEY TAKEAWAYS
25.2 STRATEGIC RECOMMENDATIONS
26 QUANTITATIVE SUMMARY
26.1 MARKET BY GEOGRAPHY
26.2 MARKET BY PRODUCT
26.3 MARKET BY SERVICE
26.4 MARKET BY END USER
26.5 NORTH AMERICA BY PRODUCT
26.6 NORTH AMERICA BY SERVICE
26.7 NORTH AMERICA BY END USER
26.8 EUROPE BY PRODUCT
26.9 EUROPE BY SERVICE
26.10 EUROPE BY END USER
26.11 APAC BY PRODUCT
26.12 APAC BY SERVICE
26.13 APAC BY END USER
26.14 LATIN AMERICA BY PRODUCT
26.15 LATIN AMERICA BY SERVICE
26.16 LATIN AMERICA BY END USER
26.17 MIDDLE EAST AND AFRICA BY PRODUCT
26.18 MIDDLE EAST AND AFRICA BY SERVICE
26.19 MIDDLE EAST AND AFRICA BY END USER
27 APPENDIX
27.1 ABBREVIATIONS
EXHIBIT 1 SEGMENTATION OF GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2022
EXHIBIT 3 MAJOR CHALLENGES FOR GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET
EXHIBIT 4 OVERVIEW OF COLD CHAIN TECHNOLOGY
EXHIBIT 5 GLOBAL BIOPHARMACEUTICAL COLD CHAIN SPENDING ($ BILLION)
EXHIBIT 6 IMPACT OF LOGISTICS CONTROL THROUGH INTERNET OF MEDICAL THINGS (IOMT)
EXHIBIT 7 IOT-ENABLED REAL-TIME COLD CHAIN MONITORING IN CONTAINER PORT
EXHIBIT 8 IOT SPENDINGS IN TRANSPORTATION AND LOGISTICS 2015 VS 2020 ($ BILLION)
EXHIBIT 9 IMPACT OF ADOPTION OF BLOCKCHAIN TECHNOLOGY
EXHIBIT 10 IMPACT OF EMERGENCE OF DIRECT-TO-PATIENT LOGISTICS SERVICES
EXHIBIT 11 BENEFITS OF DIRECT-TO-PATIENT LOGISTICS
EXHIBIT 12 IMPACT OF RISE IN NUMBER OF CLINICAL TRIALS
EXHIBIT 13 NUMBER OF CLINICAL TRIALS PER YEAR BY INCOME GROUP 2015–2019
EXHIBIT 14 IMPACT OF INCREASING COLLABORATIONS BETWEEN 3PL PROVIDERS & HEALTHCARE PROVIDERS
EXHIBIT 15 IMPACT OF SURGE IN DEMAND FOR GENERICS AND BIOSIMILARS
EXHIBIT 16 LEADING COUNTRIES IN GENERICS MARKET (2019)
EXHIBIT 17 AGGREGATE VALUE OF GLOBAL PHARMACEUTICAL INDUSTRY 2014-2021 ($ TRILLIONS)
EXHIBIT 18 IMPACT OF INCREASE IN MASS IMMUNIZATION PROGRAMS
EXHIBIT 19 IMPACT OF LACK OF COMPLIANCE & CHANGING REGULATIONS
EXHIBIT 20 COSTS INCURRED DUE TO TEMPERATURE DEVIATIONS 2019 ($ BILLION)
EXHIBIT 21 IMPACT OF GEOPOLITICAL RISKS & FLUCTUATING INTERNATIONAL TRADE REGULATORY POLICIES
EXHIBIT 22 IMPACT OF INBOUND LOGISTICS SERVICES FOR MANUFACTURERS
EXHIBIT 23 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)
EXHIBIT 24 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PRODUCT 2022 & 2028 (%)
EXHIBIT 25 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY SERVICE 2022 & 2028 (%)
EXHIBIT 26 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY END USER 2022 & 2028 (%)
EXHIBIT 27 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY GEOGRAPHY 2022 & 2028 (%)
EXHIBIT 28 FIVE FORCES ANALYSIS 2022
EXHIBIT 29 INCREMENTAL GROWTH BY PRODUCT 2022 & 2028
EXHIBIT 30 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PRODUCT
EXHIBIT 31 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PRODUCT: INCREMENTAL GROWTH ($ BILLION)
EXHIBIT 32 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PRODUCT: ABSOLUTE GROWTH ($ BILLION)
EXHIBIT 33 PHASE I-IV OF GLOBAL CLINICAL TRIALS SPENDING, DRUGS, AND BIOLOGICALS ($ BILLION)
EXHIBIT 34 NUMBER OF BIOLOGICS APPROVED AS NMES BY FDA 2017–2021
EXHIBIT 35 GLOBAL SALES OF TOP MABS 2019 ($ BILLION)
EXHIBIT 36 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PHARMACEUTICALS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 37 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PHARMACEUTICALS 2022–2028 ($ BILLION)
EXHIBIT 38 INCREMENTAL GROWTH BY GEOGRAPHY 2022 & 2028
EXHIBIT 39 GROSS DOMESTIC SPENDING ON R&D (TOTAL PERCENTAGE OF GDP) 2016–2021
EXHIBIT 40 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY MEDICAL PRODUCTS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 41 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY MEDICAL PRODUCTS 2022–2028 ($ BILLION)
EXHIBIT 42 INCREMENTAL GROWTH BY GEOGRAPHY 2022 & 2028
EXHIBIT 43 ADVANTAGES OF AIR AMBULANCE IN HEALTHCARE
EXHIBIT 44 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY OTHER PRODUCTS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 45 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY OTHER PRODUCTS 2022–2028 ($ BILLION)
EXHIBIT 46 INCREMENTAL GROWTH BY GEOGRAPHY 2022 & 2028
EXHIBIT 47 INCREMENTAL GROWTH BY SERVICE 2022 & 2028
EXHIBIT 48 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY SERVICE
EXHIBIT 49 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY SERVICE: INCREMENTAL GROWTH ($ BILLION)
EXHIBIT 50 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY SERVICE: ABSOLUTE GROWTH ($ BILLION)
EXHIBIT 51 OVERVIEW OF COMMON COLD CHAINS
EXHIBIT 52 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY TRANSPORTATION: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 53 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY TRANSPORTATION 2022–2028 ($ BILLION)
EXHIBIT 54 INCREMENTAL GROWTH BY GEOGRAPHY 2022 & 2028
EXHIBIT 55 ADVANTAGES OF OVER-THE-ROAD TRANSPORTATION
EXHIBIT 56 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY ROAD TRANSPORTATION 2022–2028 ($ BILLION)
EXHIBIT 57 ADVANTAGES OF OCEAN TRANSPORTATION
EXHIBIT 58 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY WATER TRANSPORTATION 2022–2028 ($ BILLION)
EXHIBIT 59 ADVANTAGES OF AIR TRANSPORTATION
EXHIBIT 60 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY AIR TRANSPORTATION 2022–2028 ($ BILLION)
EXHIBIT 61 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY WAREHOUSING: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 62 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY WAREHOUSING 2022–2028 ($ BILLION)
EXHIBIT 63 INCREMENTAL GROWTH BY GEOGRAPHY 2022 & 2028
EXHIBIT 64 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY OTHER SERVICES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 65 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY OTHER SERVICES 2022–2028 ($ BILLION)
EXHIBIT 66 INCREMENTAL GROWTH BY GEOGRAPHY 2022 & 2028
EXHIBIT 67 INCREMENTAL GROWTH BY END USER 2022 & 2028
EXHIBIT 68 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY END USER
EXHIBIT 69 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY END USER: INCREMENTAL GROWTH ($ BILLION)
EXHIBIT 70 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY END USER: ABSOLUTE GROWTH ($ BILLION)
EXHIBIT 71 COLD CHAIN LOGISTICS SPENDING IN PHARMACEUTICALS ($ BILLION)
EXHIBIT 72 WORLD’S BIGGEST PLAYERS RANKED BY PRESCRIPTION DRUG SALES 2021 ($ BILLION)
EXHIBIT 73 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PHARMACEUTICAL/BIOTECHNOLOGY COMPANIES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 74 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)
EXHIBIT 75 INCREMENTAL GROWTH BY GEOGRAPHY 2022 & 2028
EXHIBIT 76 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY HOSPITALS AND CLINICS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 77 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)
EXHIBIT 78 INCREMENTAL GROWTH BY GEOGRAPHY 2022 & 2028
EXHIBIT 79 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY RESEARCH AND DIAGNOSTIC LABS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 80 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)
EXHIBIT 81 INCREMENTAL GROWTH BY GEOGRAPHY 2022 & 2028
EXHIBIT 82 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY OTHER END USERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 83 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY OTHER END USERS 2022–2028 ($ BILLION)
EXHIBIT 84 INCREMENTAL GROWTH BY GEOGRAPHY 2022 & 2028
EXHIBIT 85 INCREMENTAL GROWTH BY GEOGRAPHY 2022 & 2028
EXHIBIT 86 TOP EXPORTERS OF PHARMACEUTICAL PRODUCTS WORLDWIDE 2020 ($ BILLION)
EXHIBIT 87 GEOGRAPHICAL SEGMENTATION OF SALES OF NEW MEDICINES LAUNCHED 2015–2020 (%)
EXHIBIT 88 PHARMACEUTICAL R&D EXPENDITURE: ANNUAL GROWTH RATE 2006–2020 (%)
EXHIBIT 89 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY GEOGRAPHY: INCREMENTAL GROWTH ($ BILLION)
EXHIBIT 90 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY GEOGRAPHY: ABSOLUTE GROWTH ($ BILLION)
EXHIBIT 91 PERCENTAGE OF API MANUFACTURING FACILITIES FOR ALL DRUGS BY COUNTRY OR REGION AUGUST 2019
EXHIBIT 92 NORTH AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET: KEY COUNTRIES 2022 ($ BILLION)
EXHIBIT 93 NORTH AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 94 NORTH AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)
EXHIBIT 95 INCREMENTAL GROWTH BY PRODUCT 2022 & 2028
EXHIBIT 96 INCREMENTAL GROWTH BY SERVICE 2022 & 2028
EXHIBIT 97 INCREMENTAL GROWTH BY END USER 2022 & 2028
EXHIBIT 98 INCREMENTAL GROWTH IN NORTH AMERICA 2022 & 2028
EXHIBIT 99 US PHARMACEUTICAL SALES 2017–2021 ($ BILLION)
EXHIBIT 100 US HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)
EXHIBIT 101 PERCENTAGE OF BIOLOGIC SPENDING ON BIOSIMILARS 2019–2021
EXHIBIT 102 SALES OF PATENTED AND NON-PATENTED DRUGS BY CANADIAN MANUFACTURERS 2011–2019 ($ BILLION)
EXHIBIT 103 HEALTH EXPENDITURE OF CANADIANS 2011–2019 ($ BILLION)
EXHIBIT 104 IMPORTS AND EXPORTS OF PHARMACEUTICAL AND MEDICINAL PRODUCTS NOVEMBER 2019–NOVEMBER 2021 ($ MILLION)
EXHIBIT 105 CANADA HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)
EXHIBIT 106 EUROPEAN PHARMACEUTICAL MANUFACTURING VALUE 2019 ($ MILLION)
EXHIBIT 107 EUROPE HEALTHCARE COLD CHAIN LOGISTICS MARKET: KEY COUNTRIES 2022 ($ BILLION)
EXHIBIT 108 EUROPE HEALTHCARE COLD CHAIN LOGISTICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 109 EUROPE HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)
EXHIBIT 110 INCREMENTAL GROWTH BY PRODUCT 2022 & 2028
EXHIBIT 111 INCREMENTAL GROWTH BY SERVICE 2022 & 2028
EXHIBIT 112 INCREMENTAL GROWTH BY END USER 2022 & 2028
EXHIBIT 113 INCREMENTAL GROWTH IN EUROPE 2022 & 2028
EXHIBIT 114 TOTAL DRUG SALES IN GERMAN PHARMACY MARKET 2019 (MILLION PACKAGING UNITS)
EXHIBIT 115 PHARMACEUTICAL PRODUCTION IN GERMANY 2015–2018 ($ BILLION)
EXHIBIT 116 EXPORT OF PHARMACEUTICALS FROM GERMANY ($ BILLION)
EXHIBIT 117 GERMANY HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)
EXHIBIT 118 SALES REVENUE OF OTC PHARMACEUTICALS 2017–2021 ($ MILLION)
EXHIBIT 119 FRANCE HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)
EXHIBIT 120 GROWTH OF PHARMACEUTICAL WHOLESALE IN UK 2016–2021
EXHIBIT 121 KEY INSIGHTS INTO UK PHARMACEUTICAL INDUSTRY
EXHIBIT 122 UK HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)
EXHIBIT 123 ITALY HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)
EXHIBIT 124 TOTAL REVENUE FROM OTC PHARMACEUTICALS IN SPAIN 2017–2021
EXHIBIT 125 SPAIN HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)
EXHIBIT 126 PHARMACEUTICAL SPENDING BY APAC COUNTRIES 2018 ($ BILLION)
EXHIBIT 127 APAC HEALTHCARE COLD CHAIN LOGISTICS MARKET: KEY COUNTRIES 2022 ($ BILLION)
EXHIBIT 128 APAC HEALTHCARE COLD CHAIN LOGISTICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 129 APAC HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)
EXHIBIT 130 INCREMENTAL GROWTH BY PRODUCT 2022 & 2028
EXHIBIT 131 INCREMENTAL GROWTH BY SERVICE 2022 & 2028
EXHIBIT 132 INCREMENTAL GROWTH BY END USER 2022 & 2028
EXHIBIT 133 INCREMENTAL GROWTH IN APAC 2022 & 2028
EXHIBIT 134 REVENUE SEGMENTATION OF CHINESE PHARMACEUTICAL INDUSTRY 2018 ($ BILLION)
EXHIBIT 135 TOTAL PHARMACEUTICAL COLD CHAIN LOGISTICS COST OF CHINA 2018–2021
EXHIBIT 136 CHINA HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)
EXHIBIT 137 JAPAN HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)
EXHIBIT 138 BIOSIMILARS APPROVED BY COUNTRY AND REGION 2019
EXHIBIT 139 INTERNATIONAL TRADE (EXPORT) IN PHARMACEUTICALS ($ BILLION)
EXHIBIT 140 DRUG AND PHARMACEUTICAL EXPORT TREND IN INDIA ($ BILLION)
EXHIBIT 141 MEDICINAL DRUG EXPORTS BY INDIA (2021–2022)
EXHIBIT 142 INDIA HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)
EXHIBIT 143 DRUG EXPENDITURE DYNAMICS 1995–2020
EXHIBIT 144 SOUTH KOREA HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)
EXHIBIT 145 AUSTRALIA HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)
EXHIBIT 146 LATIN AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET: KEY COUNTRIES 2022 ($ BILLION)
EXHIBIT 147 LATIN AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 148 LATIN AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)
EXHIBIT 149 INCREMENTAL GROWTH BY PRODUCT 2022 & 2028
EXHIBIT 150 INCREMENTAL GROWTH BY SERVICE 2022 & 2028
EXHIBIT 151 INCREMENTAL GROWTH BY END-USER 2022 & 2028
EXHIBIT 152 INCREMENTAL GROWTH IN LATIN AMERICA 2022 & 2028
EXHIBIT 153 BRAZIL HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)
EXHIBIT 154 MEXICO HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)
EXHIBIT 155 SHARE OF IMPORTS AND LOCAL PRODUCTION 2020
EXHIBIT 156 SALES IN ARGENTINE PHARMACEUTICAL INDUSTRY 2017-2021 ($ BILLION)
EXHIBIT 157 OTC SALES IN ARGENTINE PHARMACEUTICAL INDUSTRY 2017−2020 (%)
EXHIBIT 158 PHARMACEUTICAL EXPORTS AND IMPORTS IN ARGENTINA 2017−2021 ($ BILLION)
EXHIBIT 159 ARGENTINA HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)
EXHIBIT 160 MIDDLE EAST & AFRICA HEALTHCARE COLD CHAIN LOGISTICS MARKET: KEY COUNTRIES 2022 ($ BILLION)
EXHIBIT 161 MIDDLE EAST & AFRICA HEALTHCARE COLD CHAIN LOGISTICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 162 MIDDLE EAST AND AFRICA HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)
EXHIBIT 163 INCREMENTAL GROWTH BY PRODUCT 2022 & 2028
EXHIBIT 164 INCREMENTAL GROWTH BY SERVICE 2022 & 2028
EXHIBIT 165 INCREMENTAL GROWTH BY END-USER 2022 & 2028
EXHIBIT 166 INCREMENTAL GROWTH IN MIDDLE EAST AND AFRICA 2022 & 2028
EXHIBIT 167 SHARE OF BIOSIMILARS BY THERAPEUTIC AREAS 2020 (%)
EXHIBIT 168 TURKEY PHARMACEUTICALS MARKET COMPOSITION 2019 ($ BILLION)
EXHIBIT 169 TURKEY PHARMACEUTICALS MARKET COMPOSITION 2019 ($ BILLION)
EXHIBIT 170 TURKEY HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)
EXHIBIT 171 SAUDI ARABIA PHARMACEUTICALS MARKET COMPOSITION 2019 ($ BILLION)
EXHIBIT 172 SAUDI ARABIA HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)
EXHIBIT 173 SOUTH AFRICA HEALTHCARE COLD CHAIN LOGISTICS MARKET 2022–2028 ($ BILLION)
EXHIBIT 174 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET: CAPABILITIES & EXPERTISE ASSESSMENT
EXHIBIT 175 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET: MARKET DOMINANT ANALYSIS
EXHIBIT 176 AMERISOURCEBERGEN: TOTAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 177 DB GROUP: TOTAL REVENUE 2019–2021 ($ BILLION)
EXHIBIT 178 DB GROUP: DG SCHENKER SUBSIDIARY REVENUE 2019–2021 ($ BILLION)
EXHIBIT 179 DB GROUP: NET CAPITAL EXPENDITURE 2019–2021 ($ BILLION)
EXHIBIT 180 DEUTSCHE POST DHL GROUP: TOTAL REVENUE 2019-2021 ($ BILLION)
EXHIBIT 181 FEDEX: TOTAL REVENUE 2019–2021 ($ BILLION)
EXHIBIT 182 FEDEX: MAJOR SERVICE OFFERINGS
EXHIBIT 183 KUEHNE + NAGEL: TOTAL REVENUE 2019–2021 ($ BILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2016−2022
TABLE 3 PERCENTAGE SHARE OF VARIOUS BIOPHARMACEUTICALS (2015–2020)
TABLE 4 PERCENTAGE SHARE OF VARIOUS BIOPHARMACEUTICALS BETWEEN 2015 AND 2020
TABLE 5 BABY IMMUNIZATION SCHEDULE (BASED ON IAPCOI RECOMMENDATIONS)
TABLE 6 TOP SIX BEST-SELLING COVID-19 VACCINES 2021 ($ BILLION)
TABLE 7 NUMBER OF ORGANS TRANSPLANTED IN 2018 (IN 28 EU COUNTRIES WITH 509.7 MILLION INHABITANTS)
TABLE 8 TOTAL PHARMACEUTICALS MARKET ($ THOUSANDS), 2017−2020
TABLE 9 AMERISOURCEBERGEN: MAJOR SERVICE OFFERINGS
TABLE 10 DB SCHENKER: MAJOR SERVICE OFFERINGS
TABLE 11 DEUTSCHE POST DHL GROUP: MAJOR SERVICE OFFERINGS
TABLE 12 CEVA LOGISTICS: MAJOR SERVICE OFFERINGS
TABLE 13 UNITED PARCEL SERVICE: MAJOR SERVICE OFFERINGS
TABLE 14 KUEHNE + NAGEL: MAJOR SERVICE OFFERINGS
TABLE 15 AWL INDIA: MAJOR SERVICE OFFERINGS
TABLE 16 ALLOGA: MAJOR SERVICE OFFERINGS
TABLE 17 A.P. MOLLER - MAERSK: MAJOR SERVICE OFFERINGS
TABLE 18 AZENTA: MAJOR PRODUCT OFFERINGS
TABLE 19 COLD CHAIN TECHNOLOGIES: MAJOR SERVICE OFFERINGS
TABLE 20 COREX LOGISTICS: MAJOR SERVICE OFFERINGS
TABLE 21 CARDINAL HEALTH: MAJOR SERVICE OFFERINGS
TABLE 22 DPD: MAJOR SERVICE OFFERINGS
TABLE 23 DSV: MAJOR SERVICE OFFERINGS
TABLE 24 FARMASOFT: MAJOR SERVICE OFFERINGS
TABLE 25 GXO LOGISTICS: MAJOR SERVICE OFFERINGS
TABLE 26 KERRY LOGISTICS NETWORK: MAJOR PRODUCT OFFERINGS
TABLE 27 LUFTHANSA CARGO: MAJOR SERVICE OFFERINGS
TABLE 28 LOGISTA: MAJOR PRODUCT OFFERINGS
TABLE 29 NIPPON EXPRESS: MAJOR SERVICE OFFERINGS
TABLE 30 NOATUM LOGISTICS: MAJOR SERVICE OFFERINGS
TABLE 31 PHOENIX GROUP: MAJOR SERVICE OFFERINGS
TABLE 32 PAREXEL INTERNATIONAL: MAJOR SERVICE OFFERINGS
TABLE 33 QUICK INTERNATIONAL COURIER: MAJOR PRODUCT OFFERINGS
TABLE 34 SEKO LOGISTICS: MAJOR SERVICE OFFERINGS
TABLE 35 SINOTRANS: MAJOR SERVICE OFFERINGS
TABLE 36 YOURWAY: MAJOR SERVICE OFFERINGS
TABLE 37 YUSEN LOGISTICS: MAJOR SERVICE OFFERINGS
TABLE 38 YSDS: MAJOR PRODUCT OFFERINGS
TABLE 39 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 40 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 41 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PRODUCT 2022–2028 ($ BILLION)
TABLE 42 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PRODUCT 2022–2028 (%)
TABLE 43 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY SERVICE 2022–2028 ($ BILLION)
TABLE 44 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY SERVICE 2022–2028 (%)
TABLE 45 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY END USER 2022–2028 ($ BILLION)
TABLE 46 GLOBAL HEALTHCARE COLD CHAIN LOGISTICS MARKET BY SERVICE 2022–2028 (%)
TABLE 47 NORTH AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PRODUCT 2022–2028 ($ BILLION)
TABLE 48 NORTH AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PRODUCT 2022–2028 (%)
TABLE 49 NORTH AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY SERVICE 2022–2028 ($ BILLION)
TABLE 50 NORTH AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY SERVICE 2022–2028 (%)
TABLE 51 NORTH AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY END USER 2022–2028 ($ BILLION)
TABLE 52 NORTH AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY END USER 2022–2028 (%)
TABLE 53 EUROPE HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PRODUCT 2022–2028 ($ BILLION)
TABLE 54 EUROPE HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PRODUCT 2022–2028 (%)
TABLE 55 EUROPE HEALTHCARE COLD CHAIN LOGISTICS MARKET BY SERVICE 2022–2028 ($ BILLION)
TABLE 56 EUROPE HEALTHCARE COLD CHAIN LOGISTICS MARKET BY SERVICE 2022–2028 (%)
TABLE 57 EUROPE HEALTHCARE COLD CHAIN LOGISTICS MARKET BY END USER 2022–2028 ($ BILLION)
TABLE 58 EUROPE HEALTHCARE COLD CHAIN LOGISTICS MARKET BY END USER 2022–2028 (%)
TABLE 59 APAC HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PRODUCT 2022–2028 ($ BILLION)
TABLE 60 APAC HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PRODUCT 2022–2028 (%)
TABLE 61 APAC HEALTHCARE COLD CHAIN LOGISTICS MARKET BY SERVICE 2022–2028 ($ BILLION)
TABLE 62 APAC HEALTHCARE COLD CHAIN LOGISTICS MARKET BY SERVICE 2022–2028 (%)
TABLE 63 APAC HEALTHCARE COLD CHAIN LOGISTICS MARKET BY END USER 2022–2028 ($ BILLION)
TABLE 64 APAC HEALTHCARE COLD CHAIN LOGISTICS MARKET BY END USER 2022–2028 (%)
TABLE 65 LATIN AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PRODUCT 2022–2028 ($ BILLION)
TABLE 66 LATIN AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PRODUCT 2022–2028 (%)
TABLE 67 LATIN AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY SERVICE 2022–2028 ($ BILLION)
TABLE 68 LATIN AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY SERVICE 2022–2028 (%)
TABLE 69 LATIN AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY END USER 2022–2028 ($ BILLION)
TABLE 70 LATIN AMERICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY END USER 2022–2028 (%)
TABLE 71 MIDDLE EAST AND AFRICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PRODUCT 2022–2028 ($ BILLION)
TABLE 72 MIDDLE EAST AND AFRICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY PRODUCT 2022–2028 (%)
TABLE 73 MIDDLE EAST AND AFRICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY SERVICE 2022–2028 ($ BILLION)
TABLE 74 MIDDLE EAST AND AFRICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY SERVICE 2022–2028 (%)
TABLE 75 MIDDLE EAST AND AFRICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY END USER 2022–2028 ($ BILLION)
TABLE 76 MIDDLE EAST AND AFRICA HEALTHCARE COLD CHAIN LOGISTICS MARKET BY END USER 2022–2028 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
